This project will explore (i) the possibility of targeting inflammatory MCs on the basis of specific MC markers and (ii) potential applications of this MC targeting, namely inflammation tracking and therapy of inflammatory diseases. As a consequence of the broad applicability of the anticipated deliverables in the field of inflammation, in fact reflecting the generic nature of the project, different Flemish companies have expressed a direct interest in the acivities of the project and have been assembled in a User's Committe. These biotech companies each have te capacity to absorb (part of) the deliverables of this project, in line with their specific expertise and market niche.